- Home
- ESS
as 09-17-2025 4:00pm EST
Essex Property Trust owns a portfolio of 257 apartment communities with over 62,000 units. The company focuses on owning large, high-quality properties on the West Coast in the urban and suburban submarkets of Southern California, Northern California, and Seattle.
| Founded: | 1971 | Country: | United States |
| Employees: | N/A | City: | SAN MATEO |
| Market Cap: | 17.0B | IPO Year: | 1994 |
| Target Price: | $299.68 | AVG Volume (30 days): | 369.1K |
| Analyst Decision: | Hold | Number of Analysts: | 18 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 12.44 | EPS Growth: | 54.17 |
| 52 Week Low/High: | $243.85 - $317.73 | Next Earning Date: | 10-28-2025 |
| Revenue: | $1,887,957,000 | Revenue Growth: | 9.79% |
| Revenue Growth (this year): | 3.91% | Revenue Growth (next year): | 3.75% |
Latest Essex Property Trust Inc. News
ESS Breaking Stock News: Dive into ESS Ticker-Specific Updates for Smart Investing
MT Newswires
a day ago
Goldman Sachs Adjusts Price Target on Essex Property Trust to $291 From $288, Maintains Neutral Rating
MT Newswires
2 days ago
JPMorgan Cuts Price Target on Essex Property Trust to $294 From $309
Simply Wall St.
2 days ago
Will Essex Property Trust’s (ESS) Dividend and Upbeat Guidance Mark a Turning Point in Its Strategy?
MT Newswires
3 days ago
Evercore ISI Adjusts Price Target on Essex Property Trust to $283 From $279, Maintains In Line Rating
MT Newswires
3 days ago
BMO Capital Adjusts Essex Property Trust Price Target to $310 From $317, Maintains Outperform Rating
Benzinga
3 days ago
If You Invested $10K In Essex Property Stock 10 Years Ago, How Much Would You Have Now?
Simply Wall St.
3 days ago
Essex Property Trust (ESS): A Fresh Look at Valuation After Upgraded 2025 Guidance
Business Wire
14 days ago
Essex Property Trust Declares Quarterly Distributions
Compare ESS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ESS Essex Property Trust Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.